Doctor of Pharmacy: A New Born and Emerging Course in India

2015 ◽  
Vol 1 (1) ◽  
pp. 35-41
Author(s):  
Sai Krishna G
Keyword(s):  
Drug Therapy ◽  
Clinical Pharmacy ◽  
Healthcare Providers ◽  
Pharmacy Education ◽  
Single Individual ◽  
Doctorate Degree ◽  
Pharmacy Council ◽  
Professional Doctor ◽  
Doctor Of Pharmacy ◽  
One Year

The intention behind this review work is to enable every single individual around the India thoroughly understand the emerging field in Indian pharmacy i.e., Pharm.D, newly introduced in 2008 by the Pharmacy Council of India. It gives a doctorate degree after five years of graduation and one year internship in a hospital. Clinical pharmacy denotes the practice of pharmacy beside the bed side of the patient. The Doctor of Pharmacy (Pharm.D) degree, is a professional doctor degree in pharmacy and is a global program in pharmacy education. As the practice of pharmacy evolves, requiring more clinically oriented healthcare providers, Doctor of Pharmacy (PharmD) programs expand their training to more hospital sites to expose students to the provision of safe, effective, and economic drug therapy to patients.

scholarly journals Ethics Education for Contemporary Clinical Pharmacy Practice in Nigeria: Shortfalls and Needs

2020 ◽  
Vol 10 (1) ◽  
pp. 1-5
Author(s):  
Roland N. Okoro
Keyword(s):  
Clinical Pharmacy ◽  
Curriculum Design ◽  
Ethics Education ◽  
Ethical Issues ◽  
Healthcare Providers ◽  
Pharmacy Practice ◽  
Pharmacy Education ◽  
Pharmacy Students ◽  
Pharmacy Ethics

The past decade has witnessed a shift in the ambitions of pharmacists away from the core role of dispensing medicines towards more interesting and rewarding relationships and responsibilities with other healthcare providers and patients. The patient-centred role of pharmacists has allowed ethical issues experienced in medical practice to surface in pharmacy practice, resulting in an increase in the number and variety of ethical dilemmas that pharmacists face in their routine pharmacy practice. Pharmacy education prepares pharmacy students for practice and must be in tune with the professional dynamics. Many countries that provide patient-centered pharmacy services have redesigned pharmacy ethics education while others are in various stages of revision of their curriculum in order to adequately equip future pharmacists with the rudiments required to handle ethical issues in clinical pharmacy practice. In contrast, in Nigeria, little or no pharmacy ethics is taught to pharmacy students and the challenge lies with the curriculum design and method of teaching.

The Shape of the Rho Chi Key

1984 ◽  
Vol 18 (2) ◽  
pp. 102-104
Author(s):  
Varro E. Tyler
Keyword(s):  
Human Resources ◽  
Resource Utilization ◽  
Clinical Pharmacy ◽  
Individualized Instruction ◽  
Pharmacy Education ◽  
Teaching Techniques ◽  
Instructional Methodologies ◽  
Doctor Of Pharmacy ◽  
Proper Balance

Lack of curricular balance long has been a problem in pharmacy education. Presently, excessive emphasis on individualized instruction and a failure to develop and implement innovative instructional methodologies in clinical pharmacy have resulted in programs that are severely distorted in terms of resource utilization. A proposal is made to restore a proper balance to the curriculum, to encourage elimination of outmoded instructional areas, and to promote the utilization of novel teaching techniques. If properly constructed, such a program should allow conferral of the Doctor of Pharmacy degree and examination for licensure after a period of 5½ academic years. It is suggested that the Rho Chi Society use its vast human resources to assist in the development of such a program.

scholarly journals Clinical Pharmacy Clerkship in Pakistan: A leap from paper to practice

2011 ◽  
Vol 2 (2) ◽  
Author(s):  
Nousheen Aslam ◽  
Khwaja Zafar Ahmed
Keyword(s):  
Clinical Pharmacy ◽  
Tertiary Care ◽  
Real Life ◽  
Pharmacy Education ◽  
Metropolitan City ◽  
Pharmacy Council ◽  
Tertiary Care Hospitals

This is the first article of its type to describe the advances taking place in clinical pharmacy education in Pakistan. The Pharmacy Council of Pakistan has developed a five-year Pharm.D program to replace the four-year B.Pharm degree. Completing clinical pharmacy clerkships is a prerequisite for receiving the Pharm.D degree. To meet this requirement, Ziauddin College of Pharmacy has developed a specialized clerkship program for its 4th and 5th year students. The College is fortunate to be linked with well developed tertiary care hospitals at three prime locations in the in the metropolitan city of Karachi, which provides opportunity for the students to gain exposure to real life situations and work with patients. The article presents an account of the efforts taken for development of the clinical pharmacy clerkship program, the problems encountered during its development, and the main outcomes of a clerkship program.   Type: Note

scholarly journals Evaluation of pharmacists’ awareness of illegal online pharmacies and perceived impact on safe access to medicines

2021 ◽  
Vol 5 ◽  
pp. 239920262110056
Author(s):  
John B Hertig ◽  
Shannon M James ◽  
Connor J Hummel ◽  
Matthew J Rubin
Keyword(s):  
United States ◽  
Healthcare Providers ◽  
Access To Medicines ◽  
The United States ◽  
Pharmacy Education ◽  
Electronic Survey ◽  
Medication Therapy ◽  
Online Pharmacies ◽  
Effective Medication ◽  
Selection Of

Background: An estimated 95% of all online pharmacies operate unlawfully. Illegal online pharmacies distribute substandard and falsified medical products that may result in patient harm and suboptimal treatment, leading to an overall mistrust of medications, healthcare providers, and health systems. As medication experts, pharmacists are trusted to guide patients in selection of safe and effective medication therapy. Objective: The objective of this study was to determine gaps in knowledge and recognition of the negative clinical and safety impacts associated with illegal Internet pharmacies by licensed pharmacists. Methods: A 37-question electronic survey was developed and distributed to pharmacists across the United States by email via a database from the American Pharmacists Association. Descriptive statistics was utilized to analyze data. Results: A total of 347 pharmacists from across the United States responded to at least one question in the survey. In all, 58% of pharmacists reported a lack of confidence in their ability to counsel patients on the identification of illegal pharmacy websites. Fewer than 60% of pharmacists were able to accurately identify the legitimacy of a webpage based on visual characteristics. In addition, 75% of pharmacists reported being unfamiliar with resources available to help consumers identify safe and legitimate online pharmacies. Conclusion: Integration of the topic into pharmacy education curricula, training on available resources, and additional research into the prevalence and impact of illegal pharmacy websites are necessary to ensure that pharmacists and other healthcare professionals are adequately prepared to protect their communities from the threat of illegal online pharmacies.

A PROSPECTIVE OBSERVATIONAL AND INTERVENTIONAL STUDY ON THE ROLE OF DOCTOR OF PHARMACY/CLINICAL PHARMACIST IN IDENTIFICATION, REPORTING AND MINIMIZATION OF DRUG-RELATED PROBLEMS IN PULMONARY AND CARDIOLOGY DEPARTMENTS OF ESI HOSPITAL

2021 ◽  
pp. 51-54
Author(s):  
NASIBEH GHANBARLOU ◽  
MEKKANTI MANASA REKHA ◽  
MAHSA NAZI
Keyword(s):  
Drug Therapy ◽  
Drug Regimen ◽  
Pulmonary Medicine ◽  
Pharmacy Services ◽  
Drug Related Problems ◽  
Interventional Study ◽  
Regimen Change ◽  
Rational Drug ◽  
Degree Of Acceptance ◽  
Doctor Of Pharmacy

Objective: The present study aims at implementing the doctor of pharmacy services in the identification and reporting of drug-related problems in the in-patient units of cardiology and pulmonary medicine departments of ESI Hospital, Bangalore. Methods: A prospective interventional study was conducted from September 2018 to March 2019. Determination and categorization of drug-related problems (DRPs) were performed by the pharmacist using the PCNE classification scheme for drug-related problems V5.01. The DRPs identified by the pharmacist were reported and interventions made were subsequently recorded. Results: 180 drug-related problems were identified in the study, among which the major problems were drug-drug interactions (13.88%), followed by generic substitution (10%). The mean drug-related problem per patient was found to be 1.06. A total of 196 interventions were made by the clinical pharmacists among which, 109 (55.61%), 56 (28.57%), 17 (8.67%) interventions were at the prescriber, drug, patient levels, and 14 (7.14%) cases were the rest of interventions or activities. Distributions based on type and degree of acceptance of interventions showed that among 56 drug regimen change interventions proposed by the pharmacist, only 55.35% were accepted. The results further indicated that out of 68 monitoring required interventions made by the pharmacist, and among 17 cases that required counseling by the pharmacist in verbal, 77.94% and 88.36% of cases were accepted, respectively. Also, regarding the cases that required communication between the pharmacists and other healthcare professionals, 85.36% of a total of 41 samples and all of 14 adverse drug reporting cases made in a formal note form were accepted. Conclusion: The clinical pharmacist’s/doctor of pharmacy professional’s timely interventions in the patient’s drug therapy is required to prevent or minimize the occurrence and the risk of DRP. Rational drug therapy and optimal medication safety can be achieved by clinical pharmacy services.

Clinical Pharmacy Education

1974 ◽  
Vol 8 (2) ◽  
pp. 74-74
Author(s):  
William J. Skinner
Keyword(s):  
Clinical Pharmacy ◽  
Pharmacy Education

scholarly journals Culturally Grounded Scapegoating in Response to Illness and the COVID-19 Pandemic

2021 ◽  
Vol 12 ◽  
Author(s):  
Qian Yang ◽  
Isaac F. Young ◽  
Jialin Wan ◽  
Daniel Sullivan
Keyword(s):  
Healthcare Providers ◽  
The United States ◽  
Single Individual ◽  
Cultural Variation ◽  
Sense Of Control ◽  
Exploratory Investigation ◽  
Individual Doctor ◽  
Healthcare Crisis ◽  
Path Models ◽  
Culture Effects

For years, violence against doctors and healthcare workers has been a growing social issue in China. In a recent series of studies, we provided evidence for a motivated scapegoating account of this violence. Specifically, individuals who feel that the course of their (or their family member's) illness is a threat to their sense of control are more likely to express motivation to aggress against healthcare providers. Drawing on existential theory, we propose that blaming and aggressing against a single individual represents a culturally afforded scapegoating mechanism in China. However, in an era of healthcare crisis (i.e., the global COVID-19 pandemic), it is essential to understand cultural variation in scapegoating in the context of healthcare. We therefore undertook two cross-cultural studies examining how people in the United States and China use different scapegoating responses to re-assert a sense of control during medical uncertainty. One study was conducted prior to the pandemic and allowed us to make an initial validating and exploratory investigation of the constructs of interest. The second study, conducted during the pandemic, was confirmatory and investigated mediation path models. Across the two studies, consistent evidence emerged that, both in response to COVID-related and non-COVID-related illness scenarios, Chinese (relative to U.S.) individuals are more likely to respond by aggressing against an individual doctor, while U.S. (relative to Chinese) individuals are more likely to respond by scapegoating the medical industry/system. Further, Study 2 suggests these culture effects are mediated by differential patterns of primary and secondary control-seeking.

scholarly journals The direction of clinical pharmacy education in Japan

2021 ◽  
Vol 12 ◽  
pp. 257-258
Author(s):  
Takanao Hashimoto ◽  
Naho Sasaki ◽  
Fumiyoshi Ojima
Keyword(s):  
Clinical Pharmacy ◽  
Pharmacy Education
Sign in / Sign up

Export Citation Format

Share Document